N-doped (NrGO) and non-doped (rGO) graphenic materials are prepared by oxidation and further thermal treatment under ammonia and inert atmospheres, respectively, of natural graphites of different particle sizes. An extensive characterization of graphene materials points out that the physical properties of synthesized materials, as well as the nitrogen species introduced, depend on the particle size of the starting graphite, the reduction atmospheres, and the temperature conditions used during the exfoliation treatment. These findings indicate that it is possible to tailor properties of non-doped and N-doped reduced graphene oxide, such as the number of layers, surface area, and nitrogen content, by using a simple strategy based on selecting adequate graphite sizes and convenient experimental conditions during thermal exfoliation. Additionally, the graphenic materials are successfully applied as electrocatalysts for the demanding oxygen reduction reaction (ORR). Nitrogen doping together with the starting graphite of smaller particle size (NrGO 325 -4) resulted in a more efficient ORR electrocatalyst with more positive onset potentials (E onset = 0.82 V versus RHE), superior diffusion-limiting current density (j L, 0.26V, 1600rpm = −4.05 mA cm −2 ), and selectivity to the direct four-electron pathway. Moreover, all NrGO m -4 show high tolerance to methanol poisoning in comparison with the state-of-the-art ORR electrocatalyst Pt/C and good stability.
Ramos, I. (2019). Ru nanoparticles supported on N-doped reduced graphene oxide as valuable catalyst for the selective aerobic oxidation of benzyl alcohol. Catalysis Today.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.